KMG Fiduciary Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,114
Closed -$288K 234
2023
Q4
$288K Sell
1,114
-386
-26% -$99.9K 0.03% 205
2023
Q3
$386K Sell
1,500
-196
-12% -$50.4K 0.05% 182
2023
Q2
$483K Sell
1,696
-626
-27% -$178K 0.06% 175
2023
Q1
$646K Sell
2,322
-371
-14% -$103K 0.09% 162
2022
Q4
$746K Sell
2,693
-261
-9% -$72.3K 0.12% 139
2022
Q3
$789K Sell
2,954
-3,741
-56% -$999K 0.15% 119
2022
Q2
$1.37M Sell
6,695
-707
-10% -$144K 0.25% 90
2022
Q1
$1.56M Sell
7,402
-1,922
-21% -$405K 0.25% 90
2021
Q4
$2.24M Sell
9,324
-3,984
-30% -$956K 0.35% 74
2021
Q3
$3.77M Sell
13,308
-1,029
-7% -$291K 0.64% 42
2021
Q2
$4.96M Sell
14,337
-148
-1% -$51.2K 0.88% 29
2021
Q1
$4.05M Buy
14,485
+148
+1% +$41.4K 0.79% 34
2020
Q4
$3.53M Buy
14,337
+1,287
+10% +$317K 0.74% 36
2020
Q3
$3.7M Buy
13,050
+1,064
+9% +$302K 0.92% 32
2020
Q2
$3.21M Buy
11,986
+809
+7% +$216K 0.89% 35
2020
Q1
$3.54M Buy
11,177
+430
+4% +$136K 1.15% 28
2019
Q4
$3.19M Buy
10,747
+13
+0.1% +$3.86K 0.97% 36
2019
Q3
$2.5M Sell
10,734
-200
-2% -$46.6K 0.85% 35
2019
Q2
$2.56M Buy
10,934
+162
+2% +$37.9K 0.92% 34
2019
Q1
$2.55M Sell
10,772
-1,553
-13% -$367K 0.97% 32
2018
Q4
$3.71M Buy
+12,325
New +$3.71M 1.69% 21